GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Equasens (XPAR:EQS) » Definitions » 10-Year RORE %

Equasens (XPAR:EQS) 10-Year RORE % : 17.10% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Equasens 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Equasens's 10-Year RORE % for the quarter that ended in Dec. 2023 was 17.10%.

The industry rank for Equasens's 10-Year RORE % or its related term are showing as below:

XPAR:EQS's 10-Year RORE % is ranked better than
70.65% of 293 companies
in the Healthcare Providers & Services industry
Industry Median: 6.29 vs XPAR:EQS: 17.10

Equasens 10-Year RORE % Historical Data

The historical data trend for Equasens's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Equasens 10-Year RORE % Chart

Equasens Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.82 16.36 19.29 19.66 17.10

Equasens Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.56 19.66 20.32 17.10 -

Competitive Comparison of Equasens's 10-Year RORE %

For the Health Information Services subindustry, Equasens's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Equasens's 10-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Equasens's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Equasens's 10-Year RORE % falls into.



Equasens 10-Year RORE % Calculation

Equasens's 10-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( 3.114-1.166 )/( 20.45-8.73 )
=1.948/11.72
=16.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 10-year before.


Equasens  (XPAR:EQS) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Equasens 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Equasens's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Equasens Business Description

Traded in Other Exchanges
Address
5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.

Equasens Headlines

From GuruFocus

Equus Announces Fourth Quarter Net Asset Value

By sperokesalga sperokesalga 03-29-2023

Equus Announces First Quarter Net Asset Value

By GuruFocusNews GuruFocusNews 05-12-2022

Equus Shareholders Grant Authorization to Withdraw BDC Election

By Value_Insider Value_Insider 11-03-2022

Equus Announces Third Quarter Net Asset Value

By GuruFocusNews GuruFocusNews 11-15-2021

Equus Announces Second Quarter Net Asset Value

By Value_Insider Value_Insider 11-14-2022

Equus Announces Second Quarter Net Asset Value

By Marketwired Marketwired 08-16-2021

Equus Announces Second Quarter Net Asset Value

By PurpleRose PurpleRose 08-15-2022

Equus Announces Results of Annual Shareholder Meeting

By GuruFocusNews GuruFocusNews 06-13-2022

Equus Announces Second Quarter Net Asset Value

By Marketwired 08-20-2024

Equus Announces First Quarter Net Asset Value

By GuruFocusNews GuruFocusNews 06-01-2022